LS
ECYT

Lupo Securities’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Lupo Securities’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$26K Sell
5,600
-200
-3% -$1.05K 0.2% 48
2015
Q2 		$30K Sell
5,800
-100
-2% -$600 0.12% 42
2015
Q1 		$37K Hold
5,900
– – 0.06% 173
2014
Q4 		$37.1K Buy
+5,900
New +$36K 0.02% 209

Other funds holding ECYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lupo Securities's ECYT Position: Q3 2015 in Review

Lupo Securities reduced its Endocyte, Inc. Common Stock (ECYT) stake by 3.4% in Q3 2015, selling an estimated $1.05K and leaving 5,600 shares worth $26K. The position accounts for 0.2% of the portfolio, ranked #48.

Lupo Securities first reported a position in ECYT in Q4 2014 and has held it in 4 quarters since. The position peaked at $37.1K in Q4 2014. 104 funds tracked by Wall St. Rank hold ECYT as of Q3 2015.

  • Lupo Securities held 5,600 shares of Endocyte, Inc. Common Stock worth $26K as of Q3 2015.
  • Lupo Securities sold 200 Endocyte, Inc. Common Stock shares in Q3 2015, an estimated $1.05K.
  • Endocyte, Inc. Common Stock made up 0.2% of Lupo Securities's portfolio in Q3 2015, its #48 holding.
  • Lupo Securities first reported a position in Endocyte, Inc. Common Stock in Q4 2014 and has held it in 4 quarters since.
  • Lupo Securities's Endocyte, Inc. Common Stock position peaked at $37.1K in Q4 2014.
  • 104 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q3 2015.

Based on Lupo Securities's 13F filing for Q3 2015, filed 13 Nov 2015.